264 related articles for article (PubMed ID: 12374673)
21. Expression profiling of breast tumors based on human epidermal growth factor receptor 2 status defines migration-related genes.
Cuadros M; Cano C; López FJ; López-Castro R; Concha A
Pathobiology; 2013; 80(1):32-40. PubMed ID: 22832278
[TBL] [Abstract][Full Text] [Related]
22. Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis.
Zhao C; Yasui K; Lee CJ; Kurioka H; Hosokawa Y; Oka T; Inazawa J
Cancer; 2003 Jul; 98(1):18-23. PubMed ID: 12833450
[TBL] [Abstract][Full Text] [Related]
23. VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma.
Chen H; Ye D; Xie X; Chen B; Lu W
Gynecol Oncol; 2004 Sep; 94(3):630-5. PubMed ID: 15350351
[TBL] [Abstract][Full Text] [Related]
24. Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature.
Mook S; Knauer M; Bueno-de-Mesquita JM; Retel VP; Wesseling J; Linn SC; Van't Veer LJ; Rutgers EJ
Ann Surg Oncol; 2010 May; 17(5):1406-13. PubMed ID: 20094918
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
Banes AK; Shaw S; Jenkins J; Redd H; Amiri F; Pollock DM; Marrero MB
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F653-9. PubMed ID: 14678947
[TBL] [Abstract][Full Text] [Related]
26. The role of STATs in transcriptional control and their impact on cellular function.
Bromberg J; Darnell JE
Oncogene; 2000 May; 19(21):2468-73. PubMed ID: 10851045
[TBL] [Abstract][Full Text] [Related]
27. Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer.
Yamashita H; Nishio M; Ando Y; Zhang Z; Hamaguchi M; Mita K; Kobayashi S; Fujii Y; Iwase H
Endocr Relat Cancer; 2006 Sep; 13(3):885-93. PubMed ID: 16954437
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer prognosis determined by gene expression profiling: a quantitative reverse transcriptase polymerase chain reaction study.
Espinosa E; Vara JA; Redondo A; Sánchez JJ; Hardisson D; Zamora P; Pastrana FG; Cejas P; Martínez B; Suárez A; Calero F; Barón MG
J Clin Oncol; 2005 Oct; 23(29):7278-85. PubMed ID: 16129846
[TBL] [Abstract][Full Text] [Related]
29. Activation of Stat5 by platelet-derived growth factor (PDGF) is dependent on phosphorylation sites in PDGF beta-receptor juxtamembrane and kinase insert domains.
Valgeirsdóttir S; Paukku K; Silvennoinen O; Heldin CH; Claesson-Welsh L
Oncogene; 1998 Jan; 16(4):505-15. PubMed ID: 9484840
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
33. Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events.
Quintanilla-Martinez L; Kremer M; Specht K; Calzada-Wack J; Nathrath M; Schaich R; Höfler H; Fend F
Am J Pathol; 2003 May; 162(5):1449-61. PubMed ID: 12707028
[TBL] [Abstract][Full Text] [Related]
34. Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome.
Horiguchi A; Oya M; Shimada T; Uchida A; Marumo K; Murai M
J Urol; 2002 Aug; 168(2):762-5. PubMed ID: 12131365
[TBL] [Abstract][Full Text] [Related]
35. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
[TBL] [Abstract][Full Text] [Related]
36. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
Zhang T; Ma J; Cao X
Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
[TBL] [Abstract][Full Text] [Related]
37. Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer.
Zhi X; Wang Y; Yu J; Yu J; Zhang L; Yin L; Zhou P
IUBMB Life; 2012 Nov; 64(11):911-20. PubMed ID: 23086814
[TBL] [Abstract][Full Text] [Related]
38. High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients.
Egawa C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Int J Cancer; 2002 Apr; 98(6):879-82. PubMed ID: 11948466
[TBL] [Abstract][Full Text] [Related]
39. Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.
Czaplinska D; Mieczkowski K; Supernat A; Skladanowski AC; Kordek R; Biernat W; Zaczek AJ; Romanska HM; Sadej R
Tumour Biol; 2016 Oct; 37(10):13721-13731. PubMed ID: 27476168
[TBL] [Abstract][Full Text] [Related]
40. Role of PRL-3, Snail, Cytokeratin and Vimentin expression in epithelial mesenchymal transition in breast carcinoma.
Patel NA; Patel PS; Vora HH
Breast Dis; 2015; 35(2):113-27. PubMed ID: 25547164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]